These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 6182782)
141. Human antibody against rat gastric parietal cells and kidney brush border. Ireton HJ; Muller HK; McGiven AR Clin Exp Immunol; 1971 May; 8(5):783-9. PubMed ID: 4931857 [TBL] [Abstract][Full Text] [Related]
142. A rapid, sensitive test for the detection of antibodies to DNA. Lewis RM; Stollar BD; Goldberg EB J Immunol Methods; 1973 Dec; 3(4):365-74. PubMed ID: 4599020 [No Abstract] [Full Text] [Related]
147. [Behavior of antinuclear factors in the scleroderma]. Barthelmes H Dermatol Monatsschr; 1975 Jul; 161(7):536-44. PubMed ID: 1081957 [No Abstract] [Full Text] [Related]
148. [Studies on the importance of the fluorescence-antiglobulin test and the antiglobulin-consumption test for the demonstration of antinuclear serum factors]. Mueller-Eckhardt C; Schmidt K; Becker W Blut; 1968 Jul; 17(4):227-37. PubMed ID: 4173999 [No Abstract] [Full Text] [Related]
149. [Simultaneous testing of antinuclear factors using the "Sevatest ANF set" and the standart immunofluorescence technic]. Zitnan D Fysiatr Revmatol Vestn; 1977 Dec; 55(6):350-4. PubMed ID: 340373 [No Abstract] [Full Text] [Related]
150. Quantitative studies of immunofluorescent staining. IV. Indirect immunofluorescence blocking tests with anti-perinuclear factors of human and goat origin. Wick G; Beutner EH Immunology; 1970 Jun; 18(6):821-32. PubMed ID: 4913803 [TBL] [Abstract][Full Text] [Related]
151. Relapsing polychondritis with insulin resistance and antibodies to cartilage. Rogers PH; Boden G; Tourtellotte CD Am J Med; 1973 Aug; 55(2):243-8. PubMed ID: 4579076 [No Abstract] [Full Text] [Related]
152. Comments on antinuclear antibodies. Burnham TK; Neblett TR; Fine G Arch Dermatol; 1968 Jan; 97(1):99-100. PubMed ID: 4863705 [No Abstract] [Full Text] [Related]
153. Determination of antibodies to nuclear antigens with special reference to dsDNA using indirect immunoperoxidase. Rus HG; Niculescu F; Cristea A; Malide D; Răhăian R; Climescu M; Petcovici M; Ionescu-Dorohoi T Arch Roum Pathol Exp Microbiol; 1987; 46(2):159-65. PubMed ID: 3332071 [No Abstract] [Full Text] [Related]
154. [Production of interleukin 1 and interleukin 2 in systemic lupus erythematosus]. Lin YZ; Hsieh KH Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):657-61. PubMed ID: 3498793 [No Abstract] [Full Text] [Related]
155. Antinuclear antibodies: their significance in scleroderma. Jordon RE; Deheer D; Schroeter A; Winkelmann RK Mayo Clin Proc; 1971 Feb; 46(2):111-3. PubMed ID: 4925983 [No Abstract] [Full Text] [Related]
156. Systemic lupus erythematosus in children and adolescents. Gottlieb BS; Ilowite NT Pediatr Rev; 2006 Sep; 27(9):323-30. PubMed ID: 16950937 [No Abstract] [Full Text] [Related]
157. Evaluation of various antigenic substrates for the detection of antinuclear antibodies. Tosca A; Hatzis J; Haidas A; Varelzidis A Dermatologica; 1981; 163(5):401-7. PubMed ID: 7037486 [TBL] [Abstract][Full Text] [Related]
158. [Results of the immunofluorescence technic analysis of antinuclear factors in patients with collagen diseases and a control group with various internal diseases]. Bäumer A; Brinkmann A Z Rheumaforsch; 1970; 29(11):352-7. PubMed ID: 5313186 [No Abstract] [Full Text] [Related]
159. Systemic sclerosis and multiple sclerosis. Spadaro A; Sensi F; Barrella M; Francia A J Neurol; 1999 Jun; 246(6):497-9. PubMed ID: 10431778 [No Abstract] [Full Text] [Related]